Close Menu
December 04, 2019
Sponsored by
BC Platforms

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework


This webinar discusses what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Kristy Crooks, Assistant Professor at the University of Colorado Denver, describes how CCPM approached implementation of personalized medicine and collaborated with BC Platforms to create a system for clinically-compliant workflows from raw data to report generation.

Genetic data production and integration into clinical workflows is rapidly accelerating with the rise of new technologies and consumer interest. The accumulation of large-scale health and genetic data creates significant opportunities for new insights to improve patient care and accelerate therapeutic development. There is a demand for efficient, end-to-end data processing, but a bottleneck in data management and interpretation contributes to challenges in realizing the potential of this data.

To address these challenges, CCPM, in collaboration with BC Platforms, developed an automated pipeline that enables high-throughput processing of Illumina genotype array data, pharmacogenetics reporting for clinical decision support, and direct delivery of these results through integration with the Electronic Health Record (Epic). This webinar will highlight insights gained while building this system and ways to tackle challenges associated with the shift to data driven healthcare.

Sponsored by

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.

Sponsored by
Adaptive Biotechnologies

T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, and also support the development of antibodies by B cells. 

Sponsored by

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Sponsored by

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Sponsored by
Agena Bioscience

In non-small cell lung cancer (NSCLC), early detection of emerging resistance mutations such as EGFR T790M is important in order to determine the appropriate targeted therapeutic strategy.